Chavkin Oral And Maxillofacial Surgery Llc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 414 Jericho Tpke Ste 2, New Hyde Park, NY 11040 Phone: 516-755-7960 Fax: 516-231-2136 |
Dr. Kaufman, Schabes, & Sacks, Llp Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 2035 Lakeville Rd, Suite 204, New Hyde Park, NY 11040 Phone: 516-437-2666 Fax: 516-358-6954 |
Park One Dental P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Jericho Tpke, New Hyde Park, NY 11040 Phone: 516-354-0033 Fax: 516-354-0822 |
Nassau-queens Endodontics, P.c. Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 2035 Lakeville Road, Suite 205, New Hyde Park, NY 11040 Phone: 516-437-1633 |
Dental Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 806 Jericho Turnpike, New Hyde Park, NY 11040 Phone: 516-352-7020 Fax: 516-352-4474 |
New Hyde Park Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2001 Marcus Ave Ste W90, New Hyde Park, NY 11042 Phone: 516-354-4800 |
L&l Dental Associates, Llp Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1925 New Hyde Park Rd, New Hyde Park, NY 11040 Phone: 516-358-4683 Fax: 516-358-3667 |
News Archive
An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States.
Researchers at the Friedrich Loeffler Institute in Germany have conducted a study demonstrating that raccoon dogs were a potential intermediate host in the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression.
The Alzheimer's Association recognizes four leading scientists for their contributions to advancing Alzheimer's disease and dementia research. The awards were presented during the opening session at the Alzheimer's Association International Conference 2015 in Washington, D.C.
› Verified 8 days ago